Progressive Bilateral Sensorineural Hearing Loss Induced by an Antithyroid Drug
Authors:
- Masaki SanoMSMasaki Sano
- Nobuo KitaharaNKNobuo Kitahara
- Ryutarou KunikataRKRyutarou Kunikata
- 1 November 2004
- journal article
- case report
- Published by S. Karger AG in ORL
- Vol. 66 (5) , 281-285
Abstract
We report a patient with antithyroid drug-induced progressive bilateral sensorineural hearing loss associated with myeloperoxidase-antineutrophil cytoplasmic antibodies (MPO-ANCA). While antithyroid drugs have been linked to MPO-ANCA-associated small-vessel vasculitis, sensorineural hearing loss rarely was noted. A 36-year-old man treated for hyperthyroidism with propylthiouracil (PTU) developed progressive bilateral sensorineural hearing loss accompanied by fever and arthritis. MPO-ANCA were demonstrated in serum. Distortion product otoacoustic emissions test results suggested dysfunction of outer hair cells of the organ of Corti. Inner ear blood flow impairment from ANCA-associated small-vessel vasculitis presumably caused cochlear dysfunction. PTU withdrawal and high-dose methylprednisolone administration greatly improved hearing on both sides.Keywords
This publication has 6 references indexed in Scilit:
- The use of distortion product otoacoustic emissions in the estimation of hearing and sensory cell loss in noise-damaged cochleasHearing Research, 2003
- Myeloperoxidase-antineutrophil cytoplasmic antibody-associated sensorineural hearing lossAuris Nasus Larynx, 2001
- Small-Vessel VasculitisNew England Journal of Medicine, 1997
- Coexistent membranous nephropathy and ANCA-positive crescentic glomerulonephritis in association with penicillamineNephrology Dialysis Transplantation, 1996
- Propylthiouracil-induced cutaneous vasculitis. Case presentation and review of the literature1980
- Polyarteritis nodosa and deafness A human temporal bone studyEuropean Archives of Oto-Rhino-Laryngology, 1977